Showing 1 - 13 results of 13 for search 'Sandra Bašic Kinda', query time: 0.05s Refine Results
  1. 1
    Successful Treatment of Recurrent Gastrointestinal Bleeding Due to Small Intestine Angiodysplasia and Multiple Myeloma with Thalidomide: Two Birds with One Stone

    Successful Treatment of Recurrent Gastrointestinal Bleeding Due to Small Intestine Angiodysplasia and Multiple Myeloma with Thalidomide: Two Birds with One Stone by Ida Hude, Josip Batinic, Sandra Bašic Kinda, Drazen Pulanic

    Published 2018-11-01
    Get full text
    Article
  2. 2
    Epstein-Barr virus-negative aggressive natural killer-cell leukaemia with high P-glycoprotein activity and phosphorylated extracellular signal-regulated protein kinases 1 and 2

    Epstein-Barr virus-negative aggressive natural killer-cell leukaemia with high P-glycoprotein activity and phosphorylated extracellular signal-regulated protein kinases 1 and 2 by Sanja Perkovic, Sandra Basic-Kinda, Vladimir Gasparovic, Zeljko Krznaric, Jaksa Babel, Ivana Ilic, Igor Aurer, Drago Batinic

    Published 2012-09-01
    Get full text
    Article
  3. 3
    Oral Mucormycosis and Aspergillosis in the Patient with Acute Leukemia

    Oral Mucormycosis and Aspergillosis in the Patient with Acute Leukemia by Vanja Vučićević Boras, Martin Jurlina, Vlaho Brailo, Katarina Đurić Vuković, Pavle Rončević, Sandra Bašić Kinda, Danica Vidović Juras, Dragana Gabrić

    Published 2019-01-01
    Get full text
    Article
  4. 4
    The Impact of Achieving Complete Remission Prior to Allogeneic Stem Cell Transplantation on Progression-Free Survival in Hodgkin Lymphoma

    The Impact of Achieving Complete Remission Prior to Allogeneic Stem Cell Transplantation on Progression-Free Survival in Hodgkin Lymphoma by Nadira Duraković, Zinaida Perić, Sandra Bašić Kinda, Lana Desnica, Dino Dujmović, Ivo Radman Livaja, Ranka Serventi Seiwerth, Igor Aurer, Radovan Vrhovac

    Published 2021-07-01
    Get full text
    Article
  5. 5
    P016: Reduced steroid exposure is safe and does not reduce disease control among Hodgkin Lymphoma patients treated with escalated BEACOPP (eBEACOPP)

    P016: Reduced steroid exposure is safe and does not reduce disease control among Hodgkin Lymphoma patients treated with escalated BEACOPP (eBEACOPP) by Ida Hude Dragičević, Sandra Bašić-Kinda, Dino Dujmović, Ivo Radman, Barbara Dreta, Sandra Dotlić, Lea Galunić-Bilić, Margareta Dobrenić, Marko Kralik, Pavle Rončević, Igor Aurer

    Published 2022-10-01
    Get full text
    Article
  6. 6
    Long-Term Results of IFRT vs. ISRT in Infradiaphragmal Fields in Aggressive Non-Hodgkins’s Lymphoma Patients—A Single Centre Experience

    Long-Term Results of IFRT vs. ISRT in Infradiaphragmal Fields in Aggressive Non-Hodgkins’s Lymphoma Patients—A Single Centre Experience by Lea Galunic Bilic, Fedor Santek, Zdravko Mitrovic, Sandra Basic-Kinda, Dino Dujmovic, Marijo Vodanovic, Inga Mandac Smoljanovic, Slobodanka Ostojic Kolonic, Ruzica Galunic Cicak, Igor Aurer

    Published 2024-02-01
    Get full text
    Article
  7. 7
    Efficacy and Safety of Obinutuzumab-chemotherapy Combinations in Front-line Treatment of Follicular Non-Hodgkin Lymphoma During the COVID-19 Pandemic: A Study of KROHEM, the Croatian Cooperative Group for Hematologic Diseases

    Efficacy and Safety of Obinutuzumab-chemotherapy Combinations in Front-line Treatment of Follicular Non-Hodgkin Lymphoma During the COVID-19 Pandemic: A Study of KROHEM, the Croati... by Davor Galusic, Sandra Basic-Kinda, Andela Pijuk, Vibor Milunovic, Barbara Dreta, Neven Franjic, Bozena Coha, Jasminka Sincic-Petricevic, Petar Gacina, Vlatko Pejsa, Marko Lucijanic, Igor Aurer

    Published 2022-12-01
    Get full text
    Article
  8. 8
    Bone Marrow Microenvironment Interplay and Current Clinical Practice in Multiple Myeloma: A Review of the Balkan Myeloma Study Group

    Bone Marrow Microenvironment Interplay and Current Clinical Practice in Multiple Myeloma: A Review of the Balkan Myeloma Study Group by Jelena Bila, Eirini Katodritou, Margarita Guenova, Sandra Basic-Kinda, Daniel Coriu, Milena Dapcevic, Lejla Ibricevic-Balic, Arben Ivanaj, Oliver Karanfilski, Samo Zver, Meral Beksac, Evangelos Terpos, Meletios Athanassios Dimopoulos

    Published 2021-08-01
    Get full text
    Article
  9. 9
    Reduced Corticosteroid Exposure Is Safe and Does Not Reduce Disease Control among Hodgkin Lymphoma Patients Treated with Escalated BEACOPP (eBEACOPP)

    Reduced Corticosteroid Exposure Is Safe and Does Not Reduce Disease Control among Hodgkin Lymphoma Patients Treated with Escalated BEACOPP (eBEACOPP) by Ida Hude Dragičević, Sandra Bašić-Kinda, Helena Markotić, Martina Morić-Perić, Dino Dujmović, Ivo Radman, Barbara Dreta, Snježana Dotlić, Ivana Ilić, Lea Galunić Bilić, Margareta Dobrenić, Marko Kralik, Igor Aurer

    Published 2024-03-01
    Get full text
    Article
  10. 10
    Guidelines for Diagnosis and Treatment of Chronic Lymphocytic Leukemia. Krohem B-Cll 2017

    Guidelines for Diagnosis and Treatment of Chronic Lymphocytic Leukemia. Krohem B-Cll 2017 by Branimir Jakšić, Vlatko Pejša, Slobodanka Ostojić-Kolonić, Ika Kardum-Skelin, Sandra Bašić-Kinda, Božena Coha, Velka Gverić-Krečak, Radovan Vrhovac, Ozren Jakšić, Igor Aurer, Jasminka Sinčić-Petričević, Antica Načinović-Duletić, Damir Nemet

    Published 2018-01-01
    Get full text
    Article
  11. 11
    Treatment-Related Risk Factors for Adverse Outcomes of COVID-19 in Patients Treated for Lymphoid Malignancies in the Pre-Omicron Era—A Study of KroHem, the Croatian Group for Hematologic Diseases

    Treatment-Related Risk Factors for Adverse Outcomes of COVID-19 in Patients Treated for Lymphoid Malignancies in the Pre-Omicron Era—A Study of KroHem, the Croatian Group for Hemat... by Igor Aurer, Ozren Jakšić, Sandra Bašić-Kinda, Stefan Mrđenović, Slobodanka Ostojić-Kolonić, Dominik Lozić, Hrvoje Holik, Sabina Novaković-Coha, Petra Berneš, Ivan Krečak, Martina Morić-Perić, Marino Narančić, Zdravko Mitrović, Toni Valković

    Published 2024-01-01
    Get full text
    Article
  12. 12
    Non-Myelofibrosis Chronic Myeloproliferative Neoplasm Patients Show Better Seroconversion Rates after SARS-CoV-2 Vaccination Compared to Other Hematologic Diseases: A Multicentric Prospective Study of KroHem

    Non-Myelofibrosis Chronic Myeloproliferative Neoplasm Patients Show Better Seroconversion Rates after SARS-CoV-2 Vaccination Compared to Other Hematologic Diseases: A Multicentric... by Zrinka Sertić, Marko Lucijanić, Sandra Bašić-Kinda, Ranka Serventi Seiwerth, Vlatka Periša, Dubravka Sertić, Božena Coha, Dražen Pulanić, Zinaida Perić, Lana Desnica, Mirta Mikulić, Marijo Vodanović, Ivo Radman-Livaja, Dragana Šegulja, Dunja Rogić, Toni Valković, Igor Aurer, Nadira Duraković

    Published 2022-11-01
    Get full text
    Article
  13. 13
    P832: PROSPECTIVE REAL-WORLD EVALUATION OF THE PREVALENCE OF T(11;14) IN MULTIPLE MYELOMA: THIRD INTERIM ANALYSIS FROM THE MEDICI STUDY

    P832: PROSPECTIVE REAL-WORLD EVALUATION OF THE PREVALENCE OF T(11;14) IN MULTIPLE MYELOMA: THIRD INTERIM ANALYSIS FROM THE MEDICI STUDY by Maria Gavriatopoulou, Andrew Spencer, Daniel Coriu, Fernando Escalante Barrigón, Roman Hájek, Fernanda Seguro, Norma C. Gutiérrez, Sandra Basic Kinda, Massimo Offidani, Dorotea Beatriz Eugenia Fantl, Rosane Bittencourt, Anna Lysén, Vladimir Maisnar, Elham Askari, Joaquín Martinez-Lopez, Olivia Hughes, Rebekah Taylor, Kristin Lehn, Roby Joehanes, Jeremy Ross, Carlos Hader

    Published 2023-08-01
    Get full text
    Article

Search Tools: